Boxer Capital

Boxer Capital as of June 30, 2018

Portfolio Holdings for Boxer Capital

Boxer Capital holds 26 positions in its portfolio as reported in the June 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Solid Biosciences 11.2 $99M 2.8M 35.63
Beigene (BGNE) 11.0 $97M 630k 153.73
Mirati Therapeutics 8.7 $77M 1.6M 49.30
Ptc Therapeutics I (PTCT) 7.3 $64M 1.9M 33.73
Odonate Therapeutics Ord 7.1 $62M 2.8M 22.08
Wave Life Sciences (WVE) 6.9 $61M 1.6M 38.25
Esperion Therapeutics (ESPR) 6.1 $54M 1.4M 39.19
Sarepta Therapeutics (SRPT) 5.6 $50M 375k 132.18
Medicines Company 5.2 $46M 1.3M 36.70
Rocket Pharmaceuticals (RCKT) 4.4 $39M 2.0M 19.63
Viking Therapeutics (VKTX) 4.0 $36M 3.8M 9.49
Cymabay Therapeutics 3.2 $28M 2.1M 13.42
Madrigal Pharmaceuticals (MDGL) 3.0 $27M 95k 279.69
Macrogenics (MGNX) 2.9 $26M 1.2M 20.65
Dbv Technologies S A (DBVT) 2.3 $21M 1.1M 19.29
Kiniksa Pharmaceuticals (KNSA) 2.3 $20M 1.2M 17.35
Gtx Inc Del 2.3 $20M 1.3M 15.31
Kura Oncology (KURA) 1.7 $15M 845k 18.20
Mei Pharma 1.3 $12M 2.9M 3.94
Reata Pharmaceuticals Inc Cl A 1.3 $11M 325k 34.97
Rigel Pharmaceuticals (RIGL) 0.7 $6.6M 2.3M 2.83
Bellerophon Therapeutics 0.5 $4.5M 1.9M 2.42
Sunesis Pharmaceuticals Inc Ne 0.5 $4.5M 2.1M 2.12
Novus Therapeutics 0.3 $2.3M 324k 7.00
Regulus Therapeutics 0.1 $1.1M 1.7M 0.66
Syndax Pharmaceuticals (SNDX) 0.1 $702k 100k 7.02